| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
insulin | 0.445 | 0.923 | 0.30 |
|
group | 0.700 | None | 0.963 | 3 | 0 | 1981 | 2020 | ||||||||
|
peroxisome proliferator activated receptor gamma | 0.358 | 0.885 | 2.9E-02 |
|
group | 0.500 | None | 0.935 | 3 | 0 | 1999 | 2019 | ||||||||
|
ceruloplasmin | 0.466 | 0.846 | 4.2E-10 |
|
group | 0.460 | None | 1.000 | 1 | 0 | 1995 | 2017 | ||||||||
|
adiponectin, C1Q and collagen domain containing | 0.376 | 0.885 | 4.6E-09 |
|
group | 0.400 | None | 0.967 | 3 | 0 | 2002 | 2020 | ||||||||
|
superoxide dismutase 1 | 0.379 | 0.962 | 0.18 |
|
group | 0.400 | None | 1.000 | 2 | 0 | 2001 | 2019 | ||||||||
|
paraoxonase 1 | 0.409 | 0.885 | 9.8E-11 |
|
group | 0.400 | None | 0.977 | 2 | 0 | 1998 | 2020 | ||||||||
|
catalase | 0.359 | 0.962 | 1.6E-10 |
|
group | 0.400 | None | 0.976 | 2 | 0 | 2000 | 2020 | ||||||||
|
leptin receptor | 0.433 | 0.808 | 0.99 |
|
group | 0.400 | None | 1.000 | 2 | 0 | 1996 | 2019 | ||||||||
|
peroxisome proliferator activated receptor alpha | 0.432 | 0.885 | 3.0E-02 |
|
group | 0.300 | None | 0.971 | 2 | 0 | 2000 | 2020 | ||||||||
|
potassium inwardly rectifying channel subfamily J member 11 | 0.529 | 0.615 | 1.1E-02 |
|
group | 0.200 | None | 0.985 | 9 | 0 | 2003 | 2019 | ||||||||
|
glucokinase | 0.523 | 0.808 | 0.63 |
|
group | 0.200 | None | 0.948 | 2 | 0 | 1992 | 2020 | ||||||||
|
wolframin ER transmembrane glycoprotein | 0.528 | 0.846 | 1.6E-38 |
|
group | 0.200 | None | 0.903 | 2 | 0 | 2001 | 2019 | ||||||||
|
major histocompatibility complex, class II, DR beta 1 | 0.333 | 0.923 | 1.1E-03 |
|
group | 0.200 | None | 0.971 | 2 | 0 | 1991 | 2019 | ||||||||
|
ATP binding cassette subfamily C member 8 | 0.474 | 0.846 | 8.0E-24 |
|
group | 0.200 | None | 0.957 | 2 | 0 | 1997 | 2020 | ||||||||
|
interleukin 6 | 0.248 | 0.962 | 0.32 |
|
group | 0.200 | None | 0.942 | 2 | 0 | 2001 | 2020 | ||||||||
|
major histocompatibility complex, class II, DQ beta 1 | 0.407 | 0.885 | 8.9E-03 |
|
group | 0.200 | None | 0.938 | 2 | 0 | 1991 | 2015 | ||||||||
|
lipoprotein(a) | 0.444 | 0.769 | 6.6E-89 |
|
group | 0.200 | None | 1.000 | 1 | 0 | 1993 | 2020 | ||||||||
|
transcription factor 7 like 2 | 0.485 | 0.846 | 1.00 |
|
group | 0.200 | None | 0.976 | 1 | 0 | 2006 | 2020 | ||||||||
|
HNF1 homeobox A | 0.478 | 0.846 | 0.96 |
|
group | 0.200 | None | 0.958 | 1 | 0 | 1996 | 2020 | ||||||||
|
frataxin | 0.510 | 0.654 | 0.34 |
|
group | 0.200 | None | 1.000 | 1 | 0 | 1988 | 2020 | ||||||||
|
apolipoprotein A5 | 0.587 | 0.615 | 5.6E-10 |
|
group | 0.190 | None | 1.000 | 1 | 0 | 2006 | 2014 | ||||||||
|
lipase C, hepatic type | 0.585 | 0.654 | 3.3E-07 |
|
group | 0.150 | None | 1.000 | 1 | 0 | 2002 | 2016 | ||||||||
|
serine peptidase inhibitor Kazal type 1 | 0.492 | 0.808 | 0.31 |
|
group | 0.140 | None | 1.000 | 1 | 0 | 2002 | 2013 | ||||||||
|
tRNA | 0.534 | 0.731 |
|
group | 0.130 | None | 1.000 | 1 | 0 | 2006 | 2008 | |||||||||
|
DDB1 and CUL4 associated factor 17 | 0.653 | 0.577 | 3.7E-07 |
|
group | 0.110 | None | 1.000 | 1 | 0 | 2008 | 2008 |